000 | 01241 a2200361 4500 | ||
---|---|---|---|
005 | 20250517172702.0 | ||
264 | 0 | _c20180510 | |
008 | 201805s 0 0 eng d | ||
022 | _a1750-7448 | ||
024 | 7 |
_a10.2217/imt-2017-0039 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhang, Minghui | |
245 | 0 | 0 |
_aApplication of chimeric antigen receptor-engineered T cells in ovarian cancer therapy. _h[electronic resource] |
260 |
_bImmunotherapy _c09 2017 |
||
300 |
_a851-861 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCancer Vaccines _ximmunology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGenetic Therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunotherapy, Adoptive _xmethods |
650 | 0 | 4 |
_aOvarian Neoplasms _ximmunology |
650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xgenetics |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xgenetics |
650 | 0 | 4 | _aSignal Transduction |
650 | 0 | 4 |
_aT-Lymphocytes _xphysiology |
650 | 0 | 4 | _aTranslational Research, Biomedical |
700 | 1 | _aZhang, Dr Bin | |
700 | 1 | _aShi, Huirong | |
773 | 0 |
_tImmunotherapy _gvol. 9 _gno. 10 _gp. 851-861 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2217/imt-2017-0039 _zAvailable from publisher's website |
999 |
_c27533278 _d27533278 |